Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 01, 2020
Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: June 28, 2017
Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 23, 2015
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: August 26, 2014
Showing 1-4 of 4
Last Updated: 09/26/2026